Drugs / WUSM-MGBA-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00807781 | Oct 2009 → Mar 2014 | breast cancer | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WUSM-MGBA-01 | “The plasmid mammaglobin-A DNA vaccine will be formulated as a naked plasmid DNA vaccine (WUSM-MGBA-01).” NCT00807781 ↗ |
| Modality | Vaccine | “The plasmid mammaglobin-A DNA vaccine will be formulated as a naked plasmid DNA vaccine” NCT00807781 ↗ |
| Route | Intramuscular | “All injections will be given intramuscularly using a jet delivery device.” NCT00807781 ↗ |